Abstract
Breast cancer is one of the main causes of death from malignant neoplasms in females worldwide and, for this reason, an important object of research involving the use of neoplastic stem cells (NSCs) as a primary pharmacological target. According to cumulative evidence, NSCs play a fundamental role in the development and maintenance of malignant neoplasms, especially in the face of therape…